You are not logged in (login)
Home > Research > Areas > Cancer

PHONEBOOK

Cancer

Director
Luc Bélanger
Address
9, rue McMahon
Québec (Québec)
CANADA G1R 2J6
Phone
+1 418-525-4444, extension 15281
Fax
+1 418-691-5439
Email
luc.belanger@crhdq.ulaval.ca

No active offer

All active job offers

No active study

All active clinical studies

Cancer, one of CRCHUQ’s primary research areas, is divided into six fields of study: cellular biology; functional genomics; oncology, medical physics, and experimental therapy; medicinal chemistry; clinical and translational, evaluative and epidemiological research; and psycho-oncology and palliative care. The center now has an impressive critical mass of researchers who have produced ground-breaking research on a diversity of complex subjects such as transgenesis and gene therapy.

Active research projects (see all research project in this area)

Modifications de la chromatine durant la transcription, la réplication et la réparation de l’ADN; le rôle de complexes acétyltransférases suppresseurs de tumeurs et leurs partenaires fonctionnels
Jacques Côté
Marqueurs sériques et urinaires de l’ischémie rénale lors d’une néphrectomie partielle par laparoscopie
Louis Lacombe
An Integrated Real-Time 3D Ultrasound Guidance System for Multi-catheters Breast Brachytherapy
Luc Beaulieu, Anne Dagnault
Comparative analysis of the RNAi and the microRNA pathways in C. elegans.
Martin Simard
Functional dissection of the microRNA pathway.
Martin Simard
De la philosophie des soins palliatifs aux pratiques cliniques actuelles : entre continuité et dérapage
Mireille Lavoie
2. Deuxième axe de recherche : Modèles de soins centrés sur les personnes atteintes de cancer en phase de survie
Lise Fillion
1. Premier axe de recherche: Élaboration et évaluation d’interventions visant à augmenter la qualité de vie des personnes atteintes de cancer en phase de survie
Lise Fillion
Developmental mechanisms of Hoxa5 gene regulation (IRSC)
Lucie Jeannotte
Biological impact of the loss of Hoxa5 function in mammary gland development and tumorigenesis (SRC)
Lucie Jeannotte

Recent publications (see all publications in this area)

Patel AG, De Lorenzo S, Flatten K, Poirier G, Kaufmann SH. Failure of Iniparib to Inhibit Poly(ADP-ribose) Polymerase in Vitro. Clinical cancer research : an official journal of the American Association for Cancer Research,  2012. Epub
Kotb AF, Kovac E, Kassouf W, Chin J, Fradet Y, Izawa J, Estey E, Fairey A, Rendon R, Cagiannos I, Lacombe L, Lattouf JB, Bell D, Drachenberg D, Aprikian AG. Radical cystectomy for clinically muscle invasive bladder cancer: does prior non-invasive disease affect clinical outcomes? World journal of urology,  2012. Epub
Gagnon P, Allard P, Gagnon B, Merette C, Tardif F. Delirium prevention in terminal cancer: assessment of a multicomponent intervention. Psycho-oncology,  2012. 21: 187-194
Desy O, Carignan D, de Campos-Lima PO. Short-term immunological effects of non-ethanolic short-chain alcohols. Toxicology letters,  2012. Epub
Lodde M, Lacombe L, Naselli A, Puppo P, Mian M, Fradet Y. Long-term PSA-free survival and castration-free survival with delayed antiandrogen therapy in patients with one versus two or more positive nodes at prostatectomy. World journal of urology,  2012. Epub
Laverdiere I, Caron P, Couture F, Levesque E, Guillemette C. A liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for monitoring drug exposure in hematopoietic stem cell transplant recipients. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences ,  2012. Epub
Gagnon JC, Theriault D, Guillot M, Archambault L, Beddar S, Gingras L, Beaulieu L. Dosimetric performance and array assessment of plastic scintillation detectors for stereotactic radiosurgery quality assurance. Medical physics,  2012. 39: 429
Yagi Y, Rojo MG, Kayser K, Kayser G, Laurinavicius A, Della Mea V, Levy B, Klossa J, Tearney G, Szymas J, Tsuchihashi Y, Tetu B. The First Congress of the International Academy of Digital Pathology: Digital pathology comes of age. Analytical cellular pathology (Amsterdam),  2012. 35: 1-2
Shariat SF, Chromecki TF, Cha EK, Karakiewicz PI, Sun M, Fradet Y, Isbarn H, Scherr DS, Bastian PJ, Pummer K, Fajkovic H, Sagalowsky AI, Ashfaq R, Doblinger M, Cote RJ, Lotan Y. Risk stratification of organ confined bladder cancer after radical cystectomy using cell cycle related biomarkers. The Journal of urology,  2012. 187: 457-62
Battista JJ, Clark BG, Patterson MS, Beaulieu L, Sharpe MB, Schreiner LJ, Macpherson MS, Van Dyk J. Medical physics staffing for radiation oncology: a decade of experience in Ontario, Canada. Journal of applied clinical medical physics / American College of Medical Physics,  2012. 13: 3704
© 2012 All rights reserved CRCHUQ
<-->